
  
    
      
        Background_NNP
        The_DT enzymatic_JJ cleavage_NN of_IN double-stranded_JJ (_( ds_NNS )_) RNA_NNP
        structures_NNS is_VBZ an_DT essential_JJ step_NN in_IN the_DT maturation_NN and_CC decay_NN
        of_IN many_JJ eukaryotic_JJ and_CC prokaryotic_JJ RNAs_NNP ._. Members_NNS of_IN the_DT
        ribonuclease_NN III_NNP superfamily_RB of_IN endoribonucleases_NNS [_NN 1_CD ]_NN are_VBP
        the_DT primary_JJ agents_NNS of_IN dsRNA_NN cleavage_NN [_NN 2_CD ]_NN ._. RNase_NNP III_NNP
        orthologues_NNS are_VBP conserved_JJ in_IN eukaryotes_NNS and_CC in_IN bacteria_NNS ,_,
        with_IN 
        Escherichia_NNP coli_NNS RNase_NNP III_NNP [_NN 3_CD ]_NN as_IN
        the_DT best_RBS characterized_VBN member_NN ._. 
        E_NNP ._. coli_NNS RNase_NNP III_NNP is_VBZ active_JJ as_IN a_DT
        homodimer_NN ,_, and_CC requires_VBZ a_DT divalent_NN metal_NN ion_NN (_( preferably_RB Mg_NNP
        2_CD +_NN )_) to_TO hydrolyze_NN phosphodiesters_NNS ,_, creating_VBG 5_CD '_POS -_: phosphate_NN ,_,
        3_CD '_POS -_: hydroxyl_NN product_NN termini_NN [_NN 4_CD ]_NN ._. 
        E_NNP ._. coli_NNS RNase_NNP III_NNP cleaves_NNS rRNA_NN and_CC
        mRNA_NN precursors_NNS as_IN part_NN of_IN the_DT respective_JJ maturation_NN
        pathways_NNS ._. 
        E_NNP ._. coli_NNS RNase_NNP III_NNP also_RB initiates_NNS mRNA_NN
        degradation_NN ,_, and_CC participates_VBZ in_IN antisense_NN RNA_NNP action_NN [_NN 2_CD 5_CD
        6_CD 7_CD 8_CD ]_NN ._.
        Bacterial_NNP RNase_NNP III_NNP orthologues_NNS exhibit_NN the_DT simplest_JJS
        primary_JJ structure_NN ,_, which_WDT includes_VBZ a_DT C-_NNP terminal_NN
        dsRNA-binding_JJ motif_NN (_( dsRBM_NN )_) ,_, and_CC an_DT N-_NNP terminal_NN catalytic_JJ
        (_( nuclease_NN )_) domain_NN (_( Figure_NN 1_LS )_) ._. The_DT dsRBM_NN is_VBZ present_JJ in_IN many_JJ
        other_JJ proteins_NNS that_WDT bind_NN dsRNA_NN [_NN 9_CD 10_CD ]_NN and_CC is_VBZ important_JJ
        for_IN RNase_NNP III_NNP activity_NN in_IN 
        in_IN vitro_NN [_NN 11_CD ]_NN ._. The_DT catalytic_JJ
        domain_NN contains_VBZ a_DT number_NN of_IN conserved_JJ residues_NNS ,_, including_VBG
        an_DT 11_CD amino_JJ acid_NN signature_NN motif_NN that_WDT is_VBZ a_DT distinguishing_VBG
        feature_NN of_IN RNase_NNP III_NNP orthologues_NNS ._. The_DT isolated_VBN 
        E_NNP ._. coli_NNS RNase_NNP III_NNP catalytic_JJ domain_NN ,_,
        which_WDT retains_VBZ homodimeric_JJ behavior_NN ,_, can_MD cleave_NN dsRNA_NN
        substrates_NNS under_IN specific_JJ conditions_NNS 
        in_IN vitro_NN [_NN 11_CD ]_NN ._. The_DT recently_RB
        reported_VBN crystal_NN structure_NN of_IN the_DT catalytic_JJ domain_NN of_IN 
        Aquifex_NNP aeolicus_JJ RNase_NNP III_NNP reveals_VBZ an_DT
        extensive_JJ subunit_NN interface_NN ,_, with_IN the_DT cleft_NN between_IN the_DT
        subunits_NNS predicted_VBD to_TO bind_NN dsRNA_NN [_NN 12_CD ]_NN ._. The_DT two_CD proposed_VBN
        active_JJ sites_NNS are_VBP positioned_VBN at_IN each_DT end_NN of_IN the_DT intersubunit_NN
        cleft_NN and_CC contain_VB conserved_JJ residues_NNS from_IN each_DT subunit_NN ._.
        Several_JJ highly_RB conserved_JJ carboxylic_JJ acids_NNS in_IN the_DT active_JJ
        sites_NNS bind_NN a_DT single_JJ divalent_NN metal_NN ion_NN [_NN 12_CD ]_NN ,_, and_CC one_CD of_IN
        these_DT residues_NNS has_VBZ been_VBN shown_VBN to_TO be_VB essential_JJ for_IN catalytic_JJ
        activity_NN of_IN 
        E_NNP ._. coli_NNS RNase_NNP III_NNP [_NN 13_CD ]_NN ._.
        Two_CD mammalian_JJ RNase_NNP III_NNP orthologues_NNS have_VBP been_VBN
        identified_VBN ,_, and_CC exhibit_VB common_JJ domains_NNS as_RB well_RB as_RB
        apparently_RB unique_JJ features_NNS ._. The_DT RNase_NNP III_NNP orthologue_NN
        "_'' Dicer_NNP "_'' (_( Figure_NN 1_LS )_) plays_VBZ a_DT central_JJ role_NN in_IN RNA_NNP interference_NN
        (_( RNAi_NNP )_) by_IN cleaving_VBG dsRNAs_NNS to_TO ~_NN 21_CD bp_NN fragments_NNS ,_, termed_VBD small_JJ
        interfering_VBG (_( si_NN )_) RNAs_NNP ._. The_DT siRNAs_NNS are_VBP incorporated_VBN into_IN a_DT
        macromolecular_NN complex_JJ which_WDT carries_VBZ out_IN degradation_NN of_IN
        homologous_RB RNA_NNP sequences_NNS [_NN 14_CD ]_NN ._. Dicer_NNP action_NN serves_VBZ to_TO
        inhibit_VB viral_JJ infection_NN and_CC retroposon_NN movement_NN ,_, and_CC also_RB
        plays_VBZ a_DT role_NN in_IN developmental_NN pathways_NNS by_IN cleaving_VBG
        precursors_NNS to_TO small_JJ regulatory_JJ RNAs_NNP (_( reviewed_VBN in_IN [_NN 14_CD 15_CD ]_NN
        )_) ._. The_DT predicted_VBN sequence_NN of_IN the_DT mouse_NN Dicer_NNP polypeptide_NN
        exhibits_VBZ a_DT single_JJ dsRBM_NN and_CC tandem_JJ catalytic_JJ domains_NNS ._. In_IN
        addition_NN ,_, the_DT N-_NNP terminal_NN region_NN contains_VBZ a_DT DExH_NNP /_NN DEAH_NNP RNA_NNP
        helicase_NN motif_NN and_CC a_DT PAZ_NNP (_( Pinwheel-_NNP Argonaut-_NNP Zwille_NNP )_) domain_NN ,_,
        which_WDT is_VBZ also_RB present_JJ in_IN other_JJ proteins_NNS involved_VBN in_IN RNAi_NNP [_NN
        16_CD 17_CD ]_NN ._.
        The_DT second_JJ mammalian_JJ RNase_NNP III_NNP orthologue_NN also_RB exhibits_VBZ
        a_DT single_JJ C-_NNP terminal_NN dsRBM_NN and_CC tandem_JJ catalytic_JJ domains_NNS ,_, but_CC
        is_VBZ otherwise_RB structurally_RB distinct_JJ from_IN Dicer_NNP as_IN it_PRP lacks_VBZ
        the_DT helicase_NN and_CC PAZ_NNP domains_NNS (_( Figure_NN 1_LS )_) [_NN 18_CD 19_CD ]_NN ._.
        Preliminary_JJ evidence_NN indicates_VBZ that_IN this_DT RNase_NNP III_NNP
        orthologue_NN participates_VBZ in_IN rRNA_NN maturation_NN ._. Thus_RB ,_, a_DT
        reduction_NN in_IN human_JJ RNase_NNP III_NNP levels_NNS 
        in_IN vivo_NN causes_VBZ the_DT accumulation_NN of_IN
        specific_JJ rRNA_NN processing_NN intermediates_NNS [_NN 18_CD ]_NN ._. Consistent_NNP
        with_IN this_DT functional_JJ role_NN ,_, human_JJ RNase_NNP III_NNP localizes_NNS to_TO the_DT
        nucleolus_JJ in_IN a_DT cell-cycle-dependent_JJ manner_NN [_NN 18_CD ]_NN ._. A_DT
        truncated_JJ form_NN of_IN human_JJ RNase_NNP III_NNP has_VBZ been_VBN purified_JJ and_CC
        shown_VBN to_TO cleave_NN dsRNA_NN 
        in_IN vitro_NN [_NN 18_CD ]_NN ._. However_RB ,_, little_JJ
        else_RB is_VBZ known_VBN of_IN the_DT functional_JJ roles_NNS or_CC the_DT mechanistic_JJ
        features_NNS of_IN this_DT enzyme_NN ._. We_PRP report_VBP here_RB (_( i_NNP )_) the_DT
        characteristics_NNS of_IN the_DT cDNA_NN sequence_NN and_CC predicted_VBD
        polypeptide_NN of_IN mouse_NN RNase_NNP III_NNP ,_, (_( ii_NN )_) demonstrate_VB transcript_NN
        expression_NN patterns_NNS ,_, and_CC (_( iii_NN )_) report_NN the_DT chromosomal_NN
        locations_NNS of_IN the_DT mouse_NN and_CC human_JJ RNase_NNP III_NNP genes_NNS ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Features_NNPS of_IN the_DT mouse_NN RNase_NNP III_NNP cDNA_NN
          sequence_NN
          The_DT mouse_NN RNase_NNP III_NNP cDNA_NN structure_NN was_VBD determined_VBN by_IN
          sequence_NN analysis_NN of_IN individual_JJ cDNA_NN clones_NNS (_( see_VB
          Materials_NNPS and_CC Methods_NNP )_) ,_, whose_WP$ sequences_NNS relative_JJ to_TO the_DT
          full-length_JJ sequence_NN are_VBP shown_VBN in_IN Figure_NN 2_CD ._. The_DT length_NN of_IN
          the_DT mouse_NN RNase_NNP III_NNP cDNA_NN is_VBZ 4487_CD nt_RB (_( see_VB Additional_JJ File_NNP
          1_LS )_) ,_, and_CC the_DT predicted_VBN initiation_NN codon_NN is_VBZ at_IN position_NN
          243_CD ._. This_DT prediction_NN is_VBZ based_VBN on_IN the_DT occurrence_NN of_IN three_CD
          in-frame_JJ stop_NN codons_NNS upstream_RB of_IN the_DT indicated_VBN ATG_NNP ,_,
          within_IN the_DT 242_CD nt_RB 5_CD '_POS -_: untranslated_JJ region_NN (_( 5_CD '_POS -_: UTR_NNP )_) (_( see_VB
          Additional_JJ File_NNP 1_LS )_) ._. It_PRP is_VBZ not_RB firmly_RB established_VBN if_IN the_DT
          reported_VBN 5_CD '_POS end_NN nucleotide_NN corresponds_NNS to_TO the_DT true_JJ 5_CD '_POS end_NN
          of_IN the_DT mRNA_NN ._. However_RB ,_, several_JJ independent_JJ partial_JJ cDNA_NN
          clones_NNS (_( see_VB Figure_NN 2_LS )_) contain_VB the_DT same_JJ 5_CD '_POS nucleotide_NN ._.
          There_EX is_VBZ no_DT significant_JJ sequence_NN similarity_NN of_IN the_DT mouse_NN
          5_CD '_POS -_: UTR_NNP with_IN that_DT of_IN human_JJ RNase_NNP III_NNP (_( 245_CD nt_RB )_) ._. The_DT 3_CD '_POS -_: UTR_NNP
          is_VBZ 123_CD nt_RB in_IN size_NN ,_, and_CC contains_VBZ a_DT consensus_NN
          polyadenylation_NN signal_NN (_( AAUAAA_NNP )_) 12_CD nucleotides_NNS from_IN the_DT
          poly_RB (_( A_DT )_) tail_NN ._. The_DT 3_CD '_POS -_: UTR_NNP exhibits_VBZ 87_CD %_NN identity_NN with_IN the_DT
          human_JJ 3_CD '_POS -_: UTR_NNP (_( 372_CD nt_RB )_) over_IN a_DT ~_NN 76_CD nt_RB region_NN ,_, corresponding_JJ
          to_TO positions_NNS 37_CD -_: 113_CD of_IN the_DT mouse_NN 3_CD '_POS -_: UTR_NNP and_CC positions_NNS
          39_CD -_: 115_CD of_IN the_DT human_JJ 3_CD '_POS -_: UTR_NNP ._. A_DT search_NN of_IN the_DT NCBI_NNP mouse_NN
          EST_NNP database_NN yielded_VBD five_CD independent_JJ clones_NNS which_WDT
          exhibit_NN 100_CD percent_NN sequence_NN identity_NN with_IN the_DT 3_CD '_POS -_: UTR_NNP
          (_( data_NNS not_RB shown_VBN )_) ._. The_DT predicted_VBD 3_CD '_POS -_: UTR_NNP of_IN the_DT mouse_NN RNase_NNP
          III_NNP mRNA_NN and_CC that_IN of_IN the_DT rat_NN RNase_NNP III_NNP mRNA_NN share_NN 85_CD %_NN
          nucleotide_NN identity_NN ,_, and_CC have_VBP the_DT same_JJ lengths_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          Additional_JJ File_NNP 1_CD
          Mouse_NNP RNase_NNP III_NNP cDNA_NN and_CC amino_JJ acid_NN sequences_NNS ._. The_DT
          proposed_VBN translational_NN initiation_NN codon_NN and_CC the_DT
          polyadenylation_NN signal_NN are_VBP underlined_VBD ._. The_DT three_CD in-frame_JJ
          stop_NN codons_NNS upstream_RB of_IN the_DT initiation_NN codon_NN are_VBP
          italicized_JJ ._. Nucleotide_NNP and_CC amino_JJ acid_NN positions_NNS are_VBP
          provided_VBN on_IN the_DT right_JJ ._. The_DT human_JJ RNase_NNP III_NNP amino_JJ acid_NN
          sequence_NN is_VBZ also_RB shown_VBN in_IN italics_NNS ._. The_DT shaded_JJ amino_JJ acids_NNS
          indicate_VBP residues_NNS in_IN the_DT Proline-rich_NNP region_NN ,_, the_DT RS_NNP
          domain_NN ,_, and_CC the_DT catalytic_JJ domain_NN signature_NN sequences_NNS ._.
          Three_CD potential_JJ nuclear_JJ localization_NN signals_NNS beginning_VBG at_IN
          positions_NNS 254_CD ,_, 355_CD and_CC 508_CD are_VBP underlined_VBD ._.
          Click_NNP here_RB for_IN file_NN
        
        
          Features_NNPS of_IN the_DT predicted_VBN RNase_NNP III_NNP
          polypeptide_NN
          
            The_DT dsRBM_NN and_CC catalytic_JJ domains_NNS
            Conceptual_NNP translation_NN of_IN the_DT mouse_NN RNase_NNP III_NNP cDNA_NN ,_,
            using_VBG the_DT AUG_NNP at_IN position_NN 243_CD as_IN the_DT initiation_NN codon_NN ,_,
            yields_VBZ a_DT polypeptide_NN of_IN 1373_CD amino_JJ acids_NNS with_IN a_DT
            predicted_VBN molecular_JJ mass_NN of_IN 158_CD ._. 8_CD kDa_NN and_CC a_DT pI_NN of_IN 7_CD ._. 99_CD ._.
            The_DT polypeptide_NN contains_VBZ a_DT single_JJ dsRBM_NN and_CC two_CD RNase_NNP
            III_NNP catalytic_JJ domain_NN elements_NNS (_( see_VB Additional_JJ File_NNP 1_LS )_) ._.
            The_DT RNase_NNP III_NNP domain_NN (_( i_NNP ._. e_SYM ._. the_DT two_CD catalytic_JJ domains_NNS
            and_CC dsRBM_NN )_) of_IN the_DT mouse_NN and_CC human_JJ sequences_NNS exhibit_NN 99_CD %_NN
            amino_JJ acid_NN identity_NN and_CC 88_CD %_NN nucleotide_NN sequence_NN
            identity_NN ._. Figure_NN 3_CD provides_VBZ an_DT alignment_NN of_IN the_DT RNase_NNP
            III_NNP domains_NNS of_IN the_DT mouse_NN ,_, human_JJ ,_, 
            Drosophila_NNP and_CC 
            C_NNP ._. elegans_NNS RNase_NNP III_NNP orthologues_NNS ._.
            The_DT latter_JJ two_CD sequences_NNS also_RB exhibit_NN strong_JJ
            conservation_NN of_IN sequence_NN over_IN the_DT entire_JJ length_NN of_IN the_DT
            region_NN ._. Note_VB also_RB that_IN 
            Drosophila_NNP RNase_NNP III_NNP has_VBZ a_DT
            serine-rich_JJ C-_NNP terminal_NN extension_NN [_NN 19_CD ]_NN ._. There_EX are_VBP two_CD
            catalytic_JJ domain_NN signature_NN sequences_NNS present_JJ in_IN these_DT
            orthologues_NNS ._. The_DT single_JJ signature_NN sequence_NN of_IN bacterial_JJ
            RNase_NNP III_NNP orthologues_NNS not_RB only_RB provides_VBZ residues_NNS
            essential_JJ for_IN catalysis_NNS ,_, but_CC contributes_VBZ to_TO the_DT subunit_NN
            interface_NN [_NN 12_CD ]_NN ._. It_PRP is_VBZ therefore_RB likely_JJ that_DT mouse_NN
            RNase_NNP III_NNP is_VBZ active_JJ as_IN a_DT homodimer_NN ._. If_IN so_RB ,_, the_DT
            holoenzyme_NN may_MD contain_VB four_CD active_JJ sites_NNS ._.
          
          
            The_DT Proline-rich_NNP region_NN
            A_DT proline-rich_JJ region_NN (_( PRR_NNP )_) is_VBZ present_JJ in_IN the_DT
            N-_NNP terminal_NN portion_NN of_IN the_DT polypeptide_NN (_( see_VB Additional_JJ
            File_NNP 1_LS )_) ._. Of_IN the_DT 63_CD prolines_NNS occurring_VBG in_IN the_DT PRR_NNP ,_, 62_CD
            (_( 98_CD %_NN )_) are_VBP conserved_JJ in_IN the_DT corresponding_JJ region_NN of_IN
            human_JJ RNase_NNP III_NNP ._. Repetitive_NNP proline_NN sequences_NNS tend_VBP to_TO
            adopt_VB a_DT polyproline_NN II_NNP (_( PPII_NNP )_) helix_NN ,_, consisting_VBG of_IN an_DT
            extended_VBN structure_NN with_IN three_CD residues_NNS per_IN turn_NN ._. A_DT
            proline_NN at_IN every_DT third_JJ position_NN serves_VBZ to_TO stabilize_VB the_DT
            structure_NN [_NN 20_CD ]_NN ,_, and_CC also_RB participates_VBZ in_IN hydrogen_NN
            bonds_NNS as_RB well_RB as_IN in_IN hydrophobic_JJ interactions_NNS [_NN 21_CD ]_NN ._.
            The_DT presence_NN of_IN a_DT PRR_NNP in_IN mouse_NN RNase_NNP III_NNP suggests_VBZ
            protein-protein_JJ interactions_NNS important_JJ for_IN function_NN ._.
            PRR-mediated_NNP interactions_NNS are_VBP relatively_RB weak_JJ and_CC
            reversible_JJ ,_, and_CC occur_VB with_IN the_DT PPII_NNP helix_NN in_IN the_DT
            C-_NNP terminal_NN domain_NN of_IN RNA_NNP polymerase_NN II_NNP during_IN
            transcription_NN initiation_NN and_CC elongation_NN [_NN 22_CD ]_NN ._.
          
          
            The_DT Arginine_NNP /_NN Serine_NNP (_( RS_NNP )_) domain_NN
            The_DT mouse_NN RNase_NNP III_NNP polypeptide_NN contains_VBZ an_DT RS_NNP
            domain_NN adjacent_JJ to_TO the_DT PRR_NNP (_( see_VB Additional_JJ File_NNP 1_LS )_) ._. The_DT
            13_CD positions_NNS containing_VBG the_DT RS_NNP /_NN SR_NNP dipeptide_NN motif_NN are_VBP
            shared_VBN between_IN the_DT mouse_NN and_CC human_JJ polypeptides_NNS ,_, with_IN
            an_DT overall_JJ 87_CD %_NN sequence_NN identity_NN ,_, with_IN the_DT human_JJ
            sequence_NN containing_VBG an_DT additional_JJ SR_NNP dipeptide_NN ._. RS_NNP
            domains_NNS participate_VBP in_IN protein-protein_JJ interactions_NNS ,_,
            and_CC RS_NNP domain-containing_JJ proteins_NNS play_VBP essential_JJ roles_NNS
            in_IN constitutive_JJ or_CC alternative_JJ mRNA_NN splicing_VBG [_NN 23_CD 24_CD 25_CD
            ]_NN ._. RS_NNP proteins_NNS bind_NN RNA_NNP 
            via_IN an_DT RNA_NNP recognition_NN motif_NN
            (_( RRM_NNP )_) ,_, allowing_VBG subsequent_JJ recruitment_NN of_IN splicing_VBG
            components_NNS 
            via_IN RS_NNP domain_NN interactions_NNS ._. The_DT
            presence_NN of_IN this_DT domain_NN in_IN mouse_NN RNase_NNP III_NNP suggests_VBZ
            similar_JJ protein-protein_JJ interactions_NNS involved_VBN in_IN RNA_NNP
            maturation_NN ,_, which_WDT may_MD be_VB functionally_RB associated_VBN with_IN
            components_NNS of_IN the_DT RNA_NNP splicing_VBG and_CC transport_NN
            machinery_NN ._.
          
          
            Potential_JJ sites_NNS of_IN post-translational_JJ
            modification_NN
            Psort_NNP analysis_NN of_IN the_DT predicted_VBN mouse_NN RNase_NNP III_NNP
            amino_JJ acid_NN sequence_NN indicates_VBZ three_CD potential_JJ nuclear_JJ
            localization_NN signals_NNS positioned_VBN at_IN residues_NNS 254_CD ,_, 355_CD
            and_CC 508_CD (_( see_VB Additional_JJ File_NNP 1_LS )_) ._. A_DT Prosite_NNP scan_VB
            identified_VBN multiple_JJ potential_JJ phosphorylation_NN sites_NNS for_IN
            protein_NN kinase_NN C_NNP ,_, casein_NN kinase_NN II_NNP and_CC cAMP-dependent_JJ
            protein_NN kinase_NN (_( data_NNS not_RB shown_VBN )_) ._. Some_DT of_IN these_DT signals_NNS
            may_MD be_VB involved_VBN in_IN protein_NN localization_NN ,_, as_IN it_PRP has_VBZ been_VBN
            shown_VBN that_IN human_JJ RNase_NNP III_NNP localizes_NNS to_TO the_DT nucleolus_JJ
            during_IN the_DT cell_NN cycle_NN S_NNP phase_NN [_NN 18_CD ]_NN ._.
          
        
        
          Mouse_NNP RNase_NNP III_NNP transcript_NN expression_NN
          patterns_NNS
          The_DT transcript_NN expression_NN patterns_NNS were_VBD analyzed_VBN by_IN
          RT-PCR_NNP and_CC by_IN northern_JJ blot_NN (_( Figures_NNS 4_CD A_DT ,_, 4_CD B_NNP )_) ._. The_DT analyses_NNS
          show_VBP that_IN the_DT mouse_NN RNase_NNP III_NNP transcript_NN is_VBZ expressed_VBN in_IN
          all_DT adult_NN organs_NNS examined_VBD ,_, as_RB well_RB as_IN in_IN the_DT E_NNP 13_CD ._. 5_LS
          midgestation_NN embryo_NN ,_, the_DT extraembryonic_JJ yolk_NN sac_NN ,_, and_CC the_DT
          placenta_NN ._. Northern_JJ analysis_NN (_( Figure_NN 4_CD B_NNP )_) reveals_VBZ a_DT
          transcript_NN size_NN of_IN ~_NN 4_CD ._. 5_LS kb_NN ,_, which_WDT is_VBZ consistent_JJ with_IN the_DT
          predicted_VBN length_NN of_IN the_DT cDNA_NN ,_, including_VBG a_DT poly_RB (_( A_DT )_) tail_NN ._.
          The_DT northern_JJ analysis_NN also_RB reveals_VBZ that_IN the_DT transcript_NN is_VBZ
          heavily_RB expressed_VBN in_IN brain_NN tissue_NN and_CC perhaps_RB also_RB heart_NN
          tissue_NN ,_, while_IN only_RB lightly_RB expressed_VBD in_IN skeletal_NN muscle_NN ._.
          The_DT reason_NN (_( s_VBZ )_) for_IN the_DT differential_NN levels_NNS of_IN expression_NN
          is_VBZ unclear_JJ ,_, but_CC it_PRP is_VBZ of_IN interest_NN to_TO note_VB that_IN the_DT mouse_NN
          Dicer_NNP transcript_NN is_VBZ also_RB prominently_RB expressed_VBD in_IN brain_NN
          and_CC heart_NN tissue_NN ,_, while_IN only_RB lightly_RB expressed_VBD in_IN
          skeletal_NN muscle_NN [_NN 17_CD ]_NN ._. Interestingly_RB ,_, an_DT additional_JJ
          species_NNS (_( ~_NN 3_CD ._. 5_LS kb_NN )_) is_VBZ present_JJ in_IN testis_NNS (_( Figure_NN 4_CD B_NNP )_) ,_, which_WDT
          may_MD represent_VB an_DT alternatively_RB processed_VBN form_NN of_IN the_DT
          transcript_NN ._. This_DT species_NNS is_VBZ not_RB seen_VBN in_IN the_DT testis_NNS lane_NN
          of_IN the_DT RT-PCR_NNP analysis_NN ,_, since_IN the_DT PCR_NNP primers_NNS are_VBP
          targeted_VBN to_TO the_DT 3_CD '_POS -_: UTR_NNP ,_, which_WDT is_VBZ most_RBS likely_JJ the_DT same_JJ for_IN
          the_DT two_CD transcripts_NNS ._.
        
        
          Chromosomal_NNP locations_NNS of_IN the_DT mouse_NN and_CC human_JJ
          ribonuclease_NN III_NNP genes_NNS
          The_DT mouse_NN RNase_NNP III_NNP gene_NN was_VBD mapped_VBN using_VBG fluorescent_NN 
          in_IN situ_NN hybridization_NN (_( FISH_NNP )_) ,_,
          employing_VBG a_DT partial_JJ cDNA_NN clone_NN as_IN probe_NN ._. The_DT gene_NN is_VBZ
          located_VBN in_IN the_DT proximal_NN segment_NN (_( region_NN B_NNP )_) of_IN chromosome_NN
          15_CD (_( Figure_NN 5_CD A_DT )_) ._. The_DT human_JJ ribonuclease_NN III_NNP gene_NN was_VBD
          mapped_VBN to_TO chromosome_NN 5_CD p_NN 13_CD -_: p_NN 14_CD (_( Figure_NN 5_CD B_NNP )_) ,_, a_DT region_NN that_WDT
          is_VBZ syntenic_JJ to_TO mouse_NN chromosome_NN 15_CD B_NNP ._.
        
      
      
        Conclusions_NNP
        Sequence_NNP database_NN searches_NNS and_CC other_JJ studies_NNS [_NN 17_CD ]_NN have_VBP
        revealed_VBN only_RB two_CD RNase_NNP III_NNP orthologues_NNS (_( Dicer_NNP and_CC RNase_NNP
        III_NNP )_) in_IN the_DT mouse_NN and_CC human_JJ genomes_NNS ._. However_RB ,_, the_DT presence_NN
        of_IN an_DT additional_JJ RNase_NNP III-specific_NNP transcript_NN in_IN at_IN least_JJS
        one_CD tissue_NN indicates_VBZ the_DT possibility_NN of_IN alternative_JJ forms_NNS
        of_IN RNase_NNP III_NNP ._. The_DT broad_JJ expression_NN pattern_NN suggests_VBZ a_DT
        conserved_JJ cellular_JJ function_NN for_IN mouse_NN RNase_NNP III_NNP ._. In_IN this_DT
        regard_NN ,_, sequence_NN database_NN searches_NNS and_CC a_DT southern_JJ "_'' zoo_NN "_''
        blot_NN (_( data_NNS not_RB shown_VBN )_) indicate_VBP significant_JJ conservation_NN of_IN
        the_DT RNase_NNP III_NNP gene_NN among_IN many_JJ other_JJ vertebrates_NNS ,_, including_VBG
        rat_NN ,_, rabbit_NN and_CC cow_NN ._. However_RB ,_, functional_JJ roles_NNS for_IN
        mammalian_JJ RNase_NNP III_NNP have_VBP yet_RB to_TO be_VB fully_RB defined_VBN ._. A_DT role_NN in_IN
        rRNA_NN maturation_NN is_VBZ suggested_VBN by_IN the_DT observation_NN that_DT
        antisense_NN oligodeoxynucleotide-mediated_JJ reduction_NN in_IN human_JJ
        RNase_NNP III_NNP levels_NNS also_RB causes_VBZ a_DT decrease_NN in_IN the_DT amount_NN of_IN
        5_CD ._. 8_CD S_NNP rRNA_NN and_CC a_DT concomitant_NN increase_NN in_IN the_DT 12_CD S_NNP precursor_NN
        [_NN 18_CD ]_NN ._. A_DT similar_JJ defect_NN in_IN rRNA_NN maturation_NN is_VBZ seen_VBN upon_IN
        U_NNP 8_CD snoRNA_NN depletion_NN in_IN 
        Xenopus_NNP oocytes_NNS [_NN 26_CD ]_NN ._. As_IN U_NNP 8_CD snoRNA_NN
        participates_VBZ in_IN rRNA_NN maturation_NN ,_, it_PRP is_VBZ possible_JJ that_IN an_DT
        RNase_NNP III-dependent_NNP step_NN also_RB involves_VBZ U_NNP 8_CD snoRNA_NN ._.
        Alternatively_RB ,_, a_DT role_NN for_IN RNase_NNP III_NNP in_IN the_DT maturation_NN of_IN U_NNP 8_CD
        snoRNA_NN (_( as_RB well_RB as_IN other_JJ snoRNAs_NNS )_) is_VBZ a_DT possibility_NN ._. In_IN this_DT
        regard_NN ,_, the_DT 
        S_NNP ._. cerevisiae_NN RNase_NNP III_NNP orthologue_NN
        Rnt_NNP 1_CD p_NN not_RB only_RB cleaves_NNS the_DT 35_CD S_NNP rRNA_NN precursor_NN within_IN the_DT
        3_CD '_POS -_: ETS_NNP [_NN 27_CD 28_CD 29_CD ]_NN ,_, but_CC also_RB processes_VBZ snoRNA_NN and_CC snRNA_NN
        precursors_NNS [_NN 30_CD 31_CD 32_CD 33_CD ]_NN ._. Further_RB biochemical_JJ studies_NNS
        are_VBP required_VBN to_TO identify_VB the_DT RNA_NNP targets_NNS for_IN mammalian_JJ
        RNase_NNP III_NNP and_CC to_TO determine_VB its_PRP$ involvement_NN in_IN RNA_NNP
        maturation_NN pathways_NNS ._.
      
      
        Methods_NNP
        
          Materials_NNS
          Chemicals_NNS and_CC reagents_NNS were_VBD molecular_JJ biology_NN grade_NN or_CC
          reagent_NN grade_NN and_CC were_VBD purchased_VBN from_IN Fisher_NNP Scientific_NNP
          or_CC Sigma_NNP Chemical_NNP Company_NNP ._. Restriction_NNP enzymes_NNS were_VBD
          purchased_VBN from_IN New_NNP England_NNP Biolabs_NNP and_CC were_VBD used_VBN
          according_VBG to_TO the_DT supplied_VBN instructions_NNS ._. The_DT radiolabeled_JJ
          nucleotide_NN [_NN α-_NN 32_CD P_NN ]_NN dCTP_NN (_( 3_CD ,_, 000_CD Ci_NNP /_NN mmol_NN )_) and_CC nick_NN
          translation_NN kits_NNS were_VBD purchased_VBN from_IN Amersham-_NNP Pharmacia_NNP ._.
          Oligodeoxynucleotides_NNP used_VBD for_IN DNA_NNP sequencing_VBG and_CC PCR_NNP
          were_VBD synthesized_JJ by_IN Invitrogen_NNP ._. The_DT Multiple_NNP Tissue_NNP
          Northern_NNP (_( MTN_NNP )_) blot_NN was_VBD obtained_VBN from_IN Clontech_NNP ._.
          I_PRP ._. M_NNP ._. A_DT ._. G_NNP ._. E_NNP ._. Consortium_NNP cDNA_NN clones_NNS were_VBD obtained_VBN from_IN
          Invitrogen_NNP /_NN Research_NNP Genetics_NNP ._. The_DT cDNA_NN used_VBN as_IN template_NN
          for_IN PCR_NNP cloning_VBG and_CC sequencing_VBG was_VBD obtained_VBN from_IN Clontech_NNP
          (_( Marathon-_NNP Ready_JJ cDNA_NN )_) ,_, or_CC prepared_VBD from_IN mouse_NN liver_NN or_CC
          kidney_NN RNA_NNP as_RB previously_RB described_VBD [_NN 34_CD ]_NN ._. Bacterial_NNP
          plasmids_NNS used_VBN in_IN DNA_NNP sequencing_VBG reactions_NNS were_VBD purified_JJ
          using_VBG Qiagen_NNP plasmid_NN purification_NN kits_NNS ._. DNA_NNP sequencing_VBG
          reactions_NNS employed_VBN an_DT ABI_NNP 3700_CD automated_VBN DNA_NNP Analyzer_NNP ,_,
          and_CC Big_NNP Dye_NNP terminator_NN kits_NNS ._. Sequences_NNP were_VBD assembled_VBN
          with_IN the_DT ABI_NNP DNA_NNP sequencing_VBG analysis_NN software_NN (_( v_NN 3_CD ._. 6_CD )_) ._.
        
        
          Determination_NNP of_IN the_DT mouse_NN ribonuclease_NN III_NNP cDNA_NN
          sequence_NN
          Several_JJ avenues_NNS were_VBD followed_VBN to_TO obtain_VB the_DT complete_JJ
          cDNA_NN sequence_NN for_IN mouse_NN RNase_NNP III_NNP ._. One_CD strategy_NN was_VBD based_VBN
          on_IN a_DT previous_JJ study_NN [_NN 35_CD ]_NN which_WDT identified_VBD eukaryotic_JJ
          RNase_NNP III_NNP orthologues_NNS by_IN a_DT BLAST_NN search_NN of_IN the_DT NCBI_NNP
          translated_VBN mouse_NN EST_NNP database_NN ,_, using_VBG 
          E_NNP ._. coli_NNS RNase_NNP III_NNP as_IN query_NN
          sequence_NN ._. We_PRP carried_VBD out_RP a_DT similar_JJ search_NN against_IN the_DT
          NCBI_NNP mouse_NN EST_NNP database_NN ,_, using_VBG the_DT 
          Drosophila_NNP and_CC human_JJ RNase_NNP III_NNP [_NN 18_CD
          19_CD ]_NN as_IN query_NN sequences_NNS ._. Specific_JJ clones_NNS were_VBD identified_VBN ,_,
          obtained_VBN and_CC sequenced_JJ ._. The_DT clone_NN positions_NNS and_CC accession_NN
          numbers_NNS are_VBP given_VBN in_IN Figure_NN 2_CD ._.
          In_IN a_DT second_JJ approach_NN ,_, mouse_NN kidney_NN cDNA_NN (_( Clontech_NNP
          Marathon-ready_NNP cDNA_NN )_) served_VBD as_IN a_DT template_NN for_IN PCR_NNP which_WDT
          used_VBD the_DT Advantage-_NNP 2_CD Polymerase_NNP Mix_NNP (_( Clontech_NNP )_) ._. The_DT PCR_NNP
          reaction_NN (_( 50_CD μl_NN volume_NN )_) also_RB included_VBD :_: 10_CD μM_NN each_DT primer_NN
          (_( sequences_NNS available_JJ by_IN request_NN )_) ,_, and_CC 5_CD μl_NN of_IN the_DT cDNA_NN
          preparation_NN ._. The_DT PCR_NNP conditions_NNS were_VBD :_: 94_CD °_NN for_IN 30_CD sec_NN ,_,
          then_RB 5_CD cycles_NNS of_IN 94_CD °_NN (_( 5_CD sec_NN )_) and_CC 72_CD °_NN (_( 4_CD min_NN ._. )_) ._. This_DT was_VBD
          followed_VBN by_IN 5_CD cycles_NNS of_IN :_: 94_CD °_NN (_( 5_CD sec_NN )_) and_CC 70_CD °_NN (_( 4_CD min_NN ._. )_) ._.
          The_DT final_JJ steps_NNS consisted_VBD of_IN 20_CD -_: 25_CD cycles_NNS of_IN 94_CD °_NN (_( 5_CD sec_NN ._. )_)
          and_CC 68_CD °_NN (_( 4_CD min_NN ._. )_) ._. The_DT products_NNS were_VBD purified_JJ and_CC cloned_VBN
          into_IN plasmid_NN pPICZ-C_JJ (_( Invitrogen_NNP )_) at_IN the_DT SfiI_NNP and_CC SnaB_NNP 1_CD
          sites_NNS ._. The_DT recombinant_JJ clone_NN (_( indicated_VBD in_IN Figure_NN 2_LS )_) was_VBD
          sequenced_JJ (_( Accession_NNP Number_NNP AF_NNP 533013_CD )_) ._. All_DT sequences_NNS
          obtained_VBN as_IN described_VBN above_IN were_VBD subjected_VBN to_TO a_DT series_NN of_IN
          CLUSTALW_NNP alignments_NNS ._. Additional_JJ clone_NN sequences_NNS obtained_VBN
          from_IN the_DT NCBI_NNP database_NN were_VBD used_VBN for_IN further_JJ verification_NN
          of_IN the_DT assembled_VBN sequence_NN ._. The_DT assembled_VBN cDNA_NN sequence_NN
          was_VBD subjected_VBN to_TO hypothetical_JJ translation_NN using_VBG the_DT
          "_'' Translate_NNP "_'' program_NN available_JJ on_IN the_DT EXPASY_NNP website_NN
          www_NN ._. expasy_NN ._. ch_NN ._. Functional_NNP domains_NNS were_VBD determined_VBN using_VBG
          CLUSTALW_NNP and_CC manual_JJ methods_NNS ._. The_DT molecular_JJ weight_NN was_VBD
          calculated_VBN using_VBG the_DT primary_JJ structure_NN analysis_NN program_NN
          available_JJ from_IN ExPASY_NNP proteomics_NNS tools_NNS ._. Potential_JJ
          post-translational_JJ modification_NN sites_NNS and_CC nuclear_JJ
          localization_NN signals_NNS were_VBD identified_VBN using_VBG PROSITE_NNP and_CC
          Psort_NNP programs_NNS ,_, respectively_RB www_NN ._. expasy_NN ._. ch_NN ._.
        
        
          Expression_NNP analyses_NNS
          Total_NNP RNA_NNP was_VBD obtained_VBN from_IN mouse_NN embryonic_JJ tissue_NN or_CC
          adult_NN mouse_NN organs_NNS and_CC reverse_VB transcription_NN carried_VBD out_IN
          as_IN described_VBN [_NN 34_CD ]_NN ._. For_IN each_DT tissue_NN analysis_NN ,_, PCR_NNP was_VBD
          carried_VBN out_IN in_IN a_DT 25_CD μl_NN reaction_NN volume_NN using_VBG 1_CD μl_NN of_IN the_DT
          first-strand_JJ cDNA_NN reaction_NN ,_, according_VBG to_TO the_DT Superscript_NNP
          Preamplification_NNP System_NNP for_IN First_CD Strand_NNP cDNA_NN Synthesis_NNP
          (_( Invitrogen_NNP )_) ._. Primer_NNP sequences_NNS were_VBD (_( forward_RB )_)
          5_CD '_POS -_: GGGGCCATCCCATGCTAGAA-_NNP 3_CD '_POS and_CC (_( reverse_VB )_)
          5_CD '_POS -_: CCACTCCTGCCCTCGTTTACT-_NNP 3_CD '_'' ._. PCR_NNP conditions_NNS were_VBD 95_CD °_NN C_NNP ×_NN
          10_CD min_NN ;_: 25_CD cycles_NNS of_IN 94_CD °_NN C_NNP ×_NN 1_CD min_NN ;_: 55_CD °_NN C_NNP ×_NN 1_CD min_NN ;_: 72_CD °_NN C_NNP ×_NN 1_CD
          min_NN ;_: with_IN a_DT final_JJ extension_NN of_IN 72_CD °_NN C_NNP ×_NN 5_CD min_NN ._. β-actin_JJ was_VBD
          used_VBN as_IN an_DT internal_JJ standard_NN ;_: primer_NN sequences_NNS were_VBD
          (_( forward_RB )_) 5_CD '_POS -_: CCCAACTTGATGTATGAAGG-_NNP 3_CD '_POS and_CC (_( reverse_VB )_)
          5_CD '_POS -_: TTGTGTAAGGTAAGGTGTGC-_NNP 3_CD '_'' ._. PCR_NNP conditions_NNS were_VBD 95_CD °_NN C_NNP ×_NN 1_CD
          min_NN ,_, 30_CD cycles_NNS of_IN 94_CD °_NN C_NNP ×_NN 30_CD sec_NN ,_, 58_CD °_NN C_NNP ×_NN 30_CD sec_NN ,_, 72_CD °_NN C_NNP ×_NN 1_CD
          min_NN ,_, with_IN a_DT final_JJ extension_NN of_IN 72_CD °_NN C_NNP ×_NN 3_CD min_NN ._. Reactions_NNP
          were_VBD analyzed_VBN by_IN electrophoresis_NNS in_IN 1_CD %_NN agarose_NN gels_NNS ,_, and_CC
          DNA_NNP was_VBD visualized_JJ by_IN ethidium_NN staining_VBG ._.
        
      
      
        Authors_NNP '_'' Contributions_NNP
        Author_NN 1_CD (_( KRF_NNP )_) carried_VBD out_RP the_DT sequence_NN analyses_NNS ,_, cDNA_NN
        clone_NN construction_NN and_CC 
        in-silico_JJ analyses_NNS ._. Author_NN 2_CD (_( RHN_NNP )_)
        performed_VBD the_DT expression_NN analyses_NNS ._. Author_NN 3_CD conceived_VBD of_IN
        the_DT study_NN and_CC participated_VBD in_IN its_PRP$ design_NN and_CC execution_NN ._. All_DT
        authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
